Cybrid Technologies announced the first mass delivery of optical conversion films for perovskite tandem solar modules, marking what it described as the world’s first commercial application of this ...
SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 /Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing ...
Preclinical data with TK-6302 has shown best-in-class anti-tumor efficacy, demonstrating its potential to elicit deep and ...
Ziihera® plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback